The data is big,please wait a moment......
| EWAS ID | KEGG ID | Class | Disease/Phenotype [sample size n] |
Sample groups (case/control, trait, cell type etc.) |
KEGG Pathway Name | Pathway Gene Number | Gene Number Annotated In The KEGG Pathway | Pvalue | |
| Group1 [sample size n] |
Group2 [sample size n] |
||||||||
| EWAS332 | hsa04740 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Olfactory transduction | 391 | 378 | 4.85e-006 |
| EWAS332 | hsa04925 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Aldosterone synthesis and secretion | 81 | 80 | 0.000593 |
| EWAS332 | hsa05033 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Nicotine addiction | 40 | 40 | 0 |
| EWAS332 | hsa05200 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Pathways in cancer | 396 | 380 | 7.53e-005 |
| EWAS332 | hsa05205 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Proteoglycans in cancer | 202 | 195 | 0.000862 |
| EWAS332 | hsa05217 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Basal cell carcinoma | 55 | 55 | 0 |
| EWAS332 | hsa05310 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Asthma | 28 | 28 | 0 |
| EWAS332 | hsa05340 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Primary immunodeficiency | 36 | 36 | 0 |
| EWAS332 | hsa00604 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Glycosphingolipid biosynthesis - ganglio series | 15 | 15 | 0 |